NCT00322595 Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety Disorder Status COMPLETED Phase PHASE3
NCT00322348 Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal Women Status COMPLETED Phase PHASE2
NCT00321503 Study of an Oropharyngeal Aerosolized pH Probe for Diagnosing Laryngopharyngeal Reflux (LPR) Status COMPLETED Phase N/A
NCT00321490 Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT00320268 Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT00319787 Combination Casodex® and Iressa™ in Locally Advanced Prostate Cancer Status COMPLETED Phase PHASE2
NCT00319618 Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00319306 Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy Status COMPLETED Phase PHASE3
NCT00319202 Clinical Trial to Assess the Effects of Candesartan on the Carbohydrate Metabolism of Obese Subjects Status TERMINATED Phase PHASE4
NCT00318539 Addition of Quetiapine in Obsessive Compulsive Disorder - Westenberg Study Status COMPLETED Phase PHASE2
NCT00317772 Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00317044 Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma Status COMPLETED Phase PHASE2
NCT00316082 Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise Status COMPLETED Phase PHASE3
NCT00315380 Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis Status RECRUITING Phase N/A
NCT00314782 Phase I Study of ZD4054 (Zibotentan) and Docetaxel in Patients With Metastatic HRPC Status COMPLETED Phase PHASE1
NCT00314509 Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506) Status COMPLETED Phase PHASE2